Pharmaceutical Companies
'Where's the Vaccine?' Doctors Blast Trump's Election Day COVID Promises
Trump's numerous vows to have a COVID-19 vaccine before Election Day have been criticized by physicians who said the unfulfilled campaign promises must stop.
The 2020 Sleeper Issue
Republicans should unify behind one approach with the potential to be decisive for anyone who isn't a hard partisan. That approach is to promote the right to know health care prices up front—health care price transparency.
These Are the Health Conditions the U.S Spends Most On
"The vast costs associated with health care represent one of the most important and contentious issues facing Americans today," said researcher Joseph Dieleman.
Here's Why Analysts Think the Walgreens Deal Could Tank
For starters, taking the company private could take more than $55 billion in debt, a tough move to finance amid slumping stocks.
Faulty Supply Chains Put Antibiotics out of Reach
One key factor is that people only take antibiotics for a short period of time, just until an infection clears.
Strep Vaccine Could Save Lives, Lower Health Care Costs
What will it take for pharmaceutical companies to create a viable strep vaccine?
Who Is Alex Azar? New HHS Secretary Lobbied for Pharma
Azar will be replacing Tom Price, the former HHS secretary who resigned amid a private plane scandal in September.
Watchdog Sues Administration for Drug Pricing Details
Democracy Forward is suing for details about a former pharmaceutical lobbyist's role in drug regulation.
Is a Racist 'Double Standard' Fueling a Pharma Scandal?
The maker of Botox has been accused of unethical practices—but those accusations are also raising suspicions.
Pharmacist on Trial for Meningitis Outbreak
The former supervisor of now-defunct New England Compounding Center could receive a life sentence for second-degree murder in case linked to the deaths of more than 70 people.
Big Pharma's Latest Villain: Pharmacy Benefit Managers
Pharmacy benefit managers arose to fulfill a need created by the Medicare Modernization Act. But now these companies are contributing to escalating drug prices, the very opposite of their original purpose.
The High Cost of Lowering Drug Prices the Trump Way
Without laws to enforce them, the president's ideas to control drug prices will do just the opposite.
Trump Pressures Drugmakers to Lower Prices
Trump told pharmaceutical executives the government was paying "astronomical" prices for medicines in its health programs for older, disabled and poor people and said he would soon appoint a new U.S. Food and Drug Administration leader.
Trump Claims Pharma 'Getting Away with Murder'
After his promise to bring down drug spending, the ARCA pharmaceutical index fell 2 percent.
Japan's Takeda Buys U.S. Drug Maker Ariad for $5.2bn
Takeda CFO James Kehoe said the company was on the hunt for hit drugs.
Drugmaker Valeant Seeks New CEO; Ackman Joins Board
A board committee said its five-month investigation found broad accounting problems dating back to December 2014.
Cannabis Drug Successfully Treats Epilepsy
The 120-patient trial showed patients taking Epidiolex achieved a median reduction in monthly convulsive seizures of 39 percent, statistically significant.
Why Hasn't Big Pharma Developed Mass Market Marijuana?
Significant obstacles discourage pharma companies from devoting the power needed to develop a patentable drug to take the plant's place.
Shkreli Was Caught Doing What Big Pharma Does
While other drugs companies don't raise their drug prices fiftyfold, they would if it led to fat profits.
Should Drug Prices Be Capped?
Government price fixing will produce unintended consequences in drug research and pricing.